carbamazepine has been researched along with Tremor in 18 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Tremor: Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We studied the effects of carbamazepine (CBZ) (400 and 600 mg per day) in 10 patients with cerebellar tremors in a single-blind manner." | 9.06 | Treatment of cerebellar tremors with carbamazepine: a controlled trial with long-term follow-up. ( Agnetti, V; Piras, ML; Piredda, M; Rosati, G; Sau, G; Sechi, GP; Tanca, S; Zuddas, M, 1989) |
| "Investigation of associated risk factors of valproic acid (VPA)-induced tremor helped in increasing tolerance and optimizing treatment scheme individually." | 8.12 | Investigation of the risk of valproic acid-induced tremor: clinical, neuroimaging, and genetic factors. ( Huang, S; Jian, S; Kang, H; Kirsch, HE; Lan, L; Li, C; Wang, M; Zhao, X; Zhou, Q; Zhu, S, 2022) |
| "Ophthalmoplegia is a rarely observed sign in carbamazepine and other anticonvulsant overdoses." | 5.28 | Complete external ophthalmoplegia and asterixis with carbamazepine toxicity. ( Edis, RH; Ng, K; Silbert, PL, 1991) |
| "We studied the effects of carbamazepine (CBZ) (400 and 600 mg per day) in 10 patients with cerebellar tremors in a single-blind manner." | 5.06 | Treatment of cerebellar tremors with carbamazepine: a controlled trial with long-term follow-up. ( Agnetti, V; Piras, ML; Piredda, M; Rosati, G; Sau, G; Sechi, GP; Tanca, S; Zuddas, M, 1989) |
| " Reversible dystonia may occasionally be precipitated by phenytoin or carbamazepine; asterixis by phenytoin, barbiturates or carbamazepine; and, more commonly, tremor by valproate." | 4.77 | Adverse neuropsychiatric effects of anticonvulsant drugs. ( Reynolds, EH; Trimble, MR, 1985) |
| "Investigation of associated risk factors of valproic acid (VPA)-induced tremor helped in increasing tolerance and optimizing treatment scheme individually." | 4.12 | Investigation of the risk of valproic acid-induced tremor: clinical, neuroimaging, and genetic factors. ( Huang, S; Jian, S; Kang, H; Kirsch, HE; Lan, L; Li, C; Wang, M; Zhao, X; Zhou, Q; Zhu, S, 2022) |
| "The ability of [(+-)-5-aminocarbonyl-10,11-dihydro-5H-di-benzo [a,d]cyclohepten-5,10-imine (ADCI) and its structural analogs dizocilipine (MK-801) and carbamazepine to block ethanol withdrawal seizures was tested in mice made physically dependent upon ethanol." | 3.68 | Comparison of the effects of the uncompetitive N-methyl-D-aspartate antagonist (+-)-5-aminocarbonyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine (ADCI) with its structural analogs dizocilpine (MK-801) and carbamazepine on ethanol withdrawal seizur ( Grant, KA; Rogawski, MA; Snell, LD; Tabakoff, B; Thurkauf, A, 1992) |
| "We demonstrated that stereotyped behavior and tremor induced by methamphetamine (MA) were potentiated by pretreatment with phenytoin (PNT) in mice." | 3.67 | Phenytoin potentiates methamphetamine-induced behavior in mice. ( Fukuda, T; Izumi, K; Kishita, C; Koja, T; Nomoto, M; Shimizu, T, 1984) |
| "Superior oblique myokymia is an unusual eye movement phenomenon generally considered to be a uniocular rotary microtremor easily treated with carbamazepine." | 3.66 | Superior oblique myokymia. ( Glaser, JS; Rosenberg, ML, 1983) |
| " The pharmacokinetic assessment was repeated on day 18." | 2.69 | Lack of pharmacokinetic drug interactions between tiagabine and carbamazepine or phenytoin. ( Boellner, SW; Cao, GX; Cato, A; Guenther, HJ; Gustavson, LE; Qian, JX; Sommerville, KW, 1998) |
| " Because dosage in general was moderate and serum levels were within therapeutic boundaries in most cases, the symptom seemed to have been caused by an interaction of drugs rather than by a single agent." | 1.29 | Asterixis induced by psychotropic drug treatment. ( Rittmannsberger, H, 1996) |
| " Neither dosage nor serum levels of CBZ were in a higher range." | 1.28 | Asterixis induced by carbamazepine therapy. ( Leblhuber, F; Rittmannsberger, H, 1992) |
| "Ophthalmoplegia is a rarely observed sign in carbamazepine and other anticonvulsant overdoses." | 1.28 | Complete external ophthalmoplegia and asterixis with carbamazepine toxicity. ( Edis, RH; Ng, K; Silbert, PL, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (50.00) | 18.7374 |
| 1990's | 7 (38.89) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Lan, L | 1 |
| Zhao, X | 1 |
| Jian, S | 1 |
| Li, C | 1 |
| Wang, M | 1 |
| Zhou, Q | 1 |
| Huang, S | 1 |
| Zhu, S | 1 |
| Kang, H | 1 |
| Kirsch, HE | 1 |
| Zhou, Y | 1 |
| Sood, R | 1 |
| Wang, Q | 1 |
| Carrington, B | 1 |
| Park, M | 1 |
| Young, AC | 1 |
| Birnbaum, D | 1 |
| Liu, Z | 1 |
| Ashizawa, T | 1 |
| Mullikin, JC | 1 |
| Koubeissi, MZ | 1 |
| Liu, P | 1 |
| Izumi, K | 1 |
| Nomoto, M | 1 |
| Koja, T | 1 |
| Shimizu, T | 1 |
| Kishita, C | 1 |
| Fukuda, T | 1 |
| Ambrosetto, G | 1 |
| Riva, R | 1 |
| Baruzzi, A | 1 |
| Rosenberg, ML | 1 |
| Glaser, JS | 1 |
| Frens, DB | 1 |
| Murali, MV | 1 |
| Sharma, PP | 1 |
| Koul, PB | 1 |
| Gupta, P | 1 |
| Rittmannsberger, H | 3 |
| Gustavson, LE | 1 |
| Cato, A | 1 |
| Boellner, SW | 1 |
| Cao, GX | 1 |
| Qian, JX | 1 |
| Guenther, HJ | 1 |
| Sommerville, KW | 1 |
| Chadwick, D | 1 |
| Reynolds, EH | 2 |
| Marsden, CD | 1 |
| Leblhuber, F | 2 |
| Grant, KA | 1 |
| Snell, LD | 1 |
| Rogawski, MA | 1 |
| Thurkauf, A | 1 |
| Tabakoff, B | 1 |
| Sommer, R | 1 |
| Ng, K | 1 |
| Silbert, PL | 1 |
| Edis, RH | 1 |
| Sechi, GP | 1 |
| Zuddas, M | 1 |
| Piredda, M | 1 |
| Agnetti, V | 1 |
| Sau, G | 1 |
| Piras, ML | 1 |
| Tanca, S | 1 |
| Rosati, G | 1 |
| Trimble, MR | 1 |
| Ramsay, RE | 1 |
| Björkqvist, SE | 1 |
2 reviews available for carbamazepine and Tremor
| Article | Year |
|---|---|
Adverse neuropsychiatric effects of anticonvulsant drugs.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Barbiturates; Benzodiazepines; Biogenic Amines; Carba | 1985 |
Use of phenytoin and carbamazepine in treatment of epilepsy.
Topics: Anemia, Aplastic; Carbamazepine; Cerebellar Ataxia; Chemical and Drug Induced Liver Injury; Cognitio | 1986 |
2 trials available for carbamazepine and Tremor
| Article | Year |
|---|---|
Lack of pharmacokinetic drug interactions between tiagabine and carbamazepine or phenytoin.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Dizziness; Drug Interactions; Drug Monitoring; Dr | 1998 |
Treatment of cerebellar tremors with carbamazepine: a controlled trial with long-term follow-up.
Topics: Adult; Carbamazepine; Cerebellar Diseases; Clinical Trials as Topic; Female; Follow-Up Studies; Huma | 1989 |
14 other studies available for carbamazepine and Tremor
| Article | Year |
|---|---|
Investigation of the risk of valproic acid-induced tremor: clinical, neuroimaging, and genetic factors.
Topics: Anticonvulsants; Carbamazepine; Female; Humans; Neuroimaging; Tremor; Valproic Acid | 2022 |
Clinical and genomic analysis of a large Chinese family with familial cortical myoclonic tremor with epilepsy and
Topics: Adult; Anticonvulsants; Carbamazepine; China; DNA Repeat Expansion; Electroencephalography; Epilepsi | 2021 |
Phenytoin potentiates methamphetamine-induced behavior in mice.
Topics: Animals; Apomorphine; Behavior, Animal; Brain; Carbamazepine; Drug Synergism; Humans; Male; Methamph | 1984 |
Hyperammonemia in asterixis induced by carbamazepine: two case reports.
Topics: Aged; Ammonia; Carbamazepine; Dose-Response Relationship, Drug; Female; Humans; Tremor; Trigeminal N | 1984 |
Superior oblique myokymia.
Topics: Adult; Carbamazepine; Eye Movements; Female; Humans; Hyperkinesis; Male; Middle Aged; Myoclonus; Ocu | 1983 |
Superior oblique myokymia: a treatable cause of monocular diplopia.
Topics: Adult; Carbamazepine; Diplopia; Female; Humans; Nystagmus, Pathologic; Oculomotor Muscles; Syndrome; | 1980 |
Carbamazepine therapy for infantile tremor syndrome.
Topics: Carbamazepine; Child, Preschool; Humans; Infant; Intellectual Disability; Male; Pigmentation Disorde | 1993 |
Asterixis induced by psychotropic drug treatment.
Topics: Adult; Aged; Carbamazepine; Clozapine; Female; Humans; Male; Middle Aged; Mood Disorders; Psychotrop | 1996 |
Anticonvulsant-induced dyskinesias: a comparison with dyskinesias induced by neuroleptics.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Cerebellar Diseases; Chorea; Dyskinesia, Dr | 1976 |
Asterixis induced by carbamazepine therapy.
Topics: Adult; Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Drug Therapy, Combination; | 1992 |
Comparison of the effects of the uncompetitive N-methyl-D-aspartate antagonist (+-)-5-aminocarbonyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine (ADCI) with its structural analogs dizocilpine (MK-801) and carbamazepine on ethanol withdrawal seizur
Topics: Animals; Anticonvulsants; Carbamazepine; Dizocilpine Maleate; Ethanol; Male; Mice; Mice, Inbred C57B | 1992 |
Asterixis as a side effect of carbamazepine therapy.
Topics: Antipsychotic Agents; Carbamazepine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Ma | 1991 |
Complete external ophthalmoplegia and asterixis with carbamazepine toxicity.
Topics: Carbamazepine; Drug Interactions; Drug Overdose; Erythromycin; Female; Humans; Middle Aged; Ophthalm | 1991 |
Clonidine therapy for alcohol withdrawal.
Topics: Carbamazepine; Clonidine; Diarrhea; Drug Therapy, Combination; Ethanol; Humans; Hyperhidrosis; Hyper | 1986 |